Saving changes...

Done

Error

Advanced Pulmonary Therapeutics: Management of Chronic Obstructive Pulmonary Disease

Advanced Pulmonary Therapeutics: Management of Chronic Obstructive Pulmonary Disease

Advanced Pulmonary Therapeutics: Management of Chronic Obstructive Pulmonary Disease

Daniel Hilleman, Pharm.D, FCCP
Daniel Hilleman, Pharm.D, FCCP
on behalf of Creighton University School of Pharmacy and Health Professions

$20.00 $ 20.00 $ 20.00

$20.00 $ 20.00 $ 20.00

$ 20.00 $ 20.00 $ 20.00
$ 20.00 $ 20.00 $ 20.00
Normal Price: $20.00 $20.00

Review:

Launch date: 19 Nov 2016

Expiry Date:

Last updated: 05 Apr 2017

Reference: 167118

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This course will analyse the pathophysiology of COPD, looking at the diagnostic and assessment criteria used, studying appropriate non-pharmacologic therapies for patients with COPD. This e-learning will identify the pharmacologic therapies used for patients with COPD based on symptoms and exacerbation risk. During this course participants will analyse the mechanism of action, dosing and toxicity of, and pharmacologic agent used in COPD. And ultimately differentiating the management strategy for stable COPD compared to COPD exacerbations.

Objectives

Upon completion of this course, you should be able to:
Objective 1:
Describe the pathophysiology of COPD.
Objective 2:
Describe the diagnostic and assessment criteria used in COPD
Objective 3:
Describe appropriate non-pharmacologic therapies for patients with COPD
Objective 4:
Identify pharmacologic therapies used for patients with COPD based on symptoms and exacerbation risk
Objective 5:
Describe the mechanism of action, dosing and toxicity of, and pharmacologic agent used in COPD.
Objective 6:
Differentiate the management strategy for stable COPD compared to COPD exacerbations.
Daniel Hilleman, Pharm.D, FCCP

Author Information Play Video Bio

Daniel Hilleman, Pharm.D, FCCP
on behalf of Creighton University School of Pharmacy and Health Professions

Daniel E. Hilleman was born in St. Louis, MO. He attended Loyola University in New Orleans majoring in chemistry. Dr. Hilleman graduated from Creighton University with a Doctor of Pharmacy degree. He completed a pre-doctoral fellowship in toxicology at the Poison Control Center in Omaha, NE. Dr. Hilleman joined the faculty at the Creighton University School of Pharmacy and Health Professions in 1981. He served as Administrative Director of Clinical Research at the Creighton Cardiac Center from 1985-1992. He then served as Chair, Department of Pharmacy Practice at Creighton from 1993-2003. In 2003-2004, Dr. Hilleman completed a fellowship/sabbatical in information technology and distance education. Dr. Hilleman was promoted to a Professor of Pharmacy Practice and Medicine in 1994. Dr. Hilleman has served as the primary preceptor of the Creighton Cardiac Center pharmacy research fellowship since 1983. Dr. Hilleman currently practices at the Creighton University Medical Center where he specializes in cardiovascular and critical care medicine.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error